%PDF-1.6 % 1 0 obj <> endobj 2 0 obj <>stream 2013-09-17T11:40:39+02:00 2013-09-17T11:40:38+02:00 2013-09-17T11:40:39+02:00 Adobe Acrobat 10.0 application/pdf EACS 2013 uuid:650072e1-94a6-470a-ab5c-001e0d2f07e7 uuid:543fb8c4-be32-45f9-946e-e9d7f5cc603e Acrobat Web Capture 10.0 endstream endobj 5 0 obj <> endobj 6 0 obj <> endobj 3 0 obj <> endobj 7 0 obj <> endobj 10 0 obj <>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>> endobj 11 0 obj <>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>> endobj 24 0 obj <>stream /CS0 cs 1 scn 57 426.905 480.75 400.942 re f 62.068 521.915 475.682 305.932 re f 62.068 426.905 475.682 95.01 re f 62.068 430.072 475.682 0.634 re f 0.604 scn q 1 0 0 1 62.0676 430.7058 cm 0 0 m 0.633 -0.634 l 475.049 -0.634 l 475.682 0 l h f Q 0.933 scn q 1 0 0 1 62.0676 430.0722 cm 0 0 m 0.633 0 l 475.049 0 l 475.682 0 l h f Q 0.604 scn q 1 0 0 1 62.0676 430.0722 cm 0 0 m 0.633 0 l 0 0.634 l h f Q 0.933 scn q 1 0 0 1 537.1164 430.0722 cm 0 0 m 0.634 0 l 0.634 0.634 l h f Q q 65.234 613.124 380.04 214.089 re W n q /GS0 gs 380.0395131 0 0 -214.0889257 65.2341895 827.2134278 cm /Im0 Do Q Q BT 0 scn /TT0 1 Tf 0.03 Tw 8.2342 0 0 8.2342 62.0672 602.3567 Tm [([Figure)-42( 2])]TJ /TT1 1 Tf 0 Tw 0 -3.692 TD [(Conclusion:)-68( )]TJ /TT2 1 Tf 0.03 Tw 6.154 0 Td [(Injection)-45( of)-12( cathinone/buprenorphine)-15( is)-47( associated)-66( with)-68( an)-42( extremely)-51( high)-33( risk)-60( of)-12( infections)-7( with)-68( blood)-15(-)-52(borne)]TJ -6.154 -1.231 Td [(pathogens.)-52( Our)-25( findings)-15( strongly)-37( suggest)-36( that)-24( a)-59( change)-28( in)-68( drug)-76( use)-3( patterns)-2( precipitated)-62( this)-59( ongoing)-57( outbreak)-32( of)-12( HIV)-25( infection)]TJ 0 -1.231 TD [(among)-20( IDUs)-9( and)-24( failure)-46( of)-12( previously)-37( efficient)-16( risk)-60( reduction)-41( programs.)]TJ 0 Tw /Span<>> BDC 6.334 0 0 6.334 62.0672 523.8152 Tm ( )Tj EMC /TT1 1 Tf 0.03 Tw 8.2342 0 0 8.2342 62.0672 514.3142 Tm [(Abstract)-21( Details)]TJ /TT2 1 Tf 0.154 -1.385 Td [(Abstract)-24( Number:)]TJ /Span<>> BDC 7.846 0 Td ( )Tj EMC 0 Tw 3.769 0 Td (PS11/4)Tj 0.03 Tw -11.615 -1.462 Td [(Session)-58( Title:)]TJ /Span<>> BDC 6.154 0 Td ( )Tj EMC 5.462 0 Td [(PS11)-15( -)-52( Sex,)-76( Drugs)-25( and)-24( Stigma)]TJ -11.615 -1.462 Td [(Session)-58( Date:)]TJ /Span<>> BDC 6.385 0 Td ( )Tj EMC 5.231 0 Td [(18)-42( October)-58( 2013,)-36( 14:00)-36( -)-52( 16:00)]TJ -11.615 -1.462 Td [(Session)-58( Room:)]TJ /Span<>> BDC 6.923 0 Td ( )Tj EMC 4.692 0 Td [(Copper)-29( Hall)]TJ -11.615 -2.077 Td [(Abstract)-24( Category:)]TJ /Span<>> BDC 8.385 0 Td ( )Tj EMC 3.231 0.615 Td [(21.)-71( Epidemiology)-75( \(incl.)-43( HIV)-25(-)-52(Prevalence/Incidence/Dynamics)-4( of)-12( the)-72( HIV)-25(-)-52(Epidemic,)-71( Molecular)]TJ 0 Tw T* (Epidemiology\))Tj /Span<>> BDC 6.334 0 0 6.334 62.0672 435.7727 Tm ( )Tj EMC ET endstream endobj 13 0 obj <> endobj 14 0 obj (gQO89A&) endobj 26 0 obj <>stream Adobe d '$''''$25552;;;;;;;;;; %%#(((((#,0000,7;;;7;;;;;;;;;; %%#(((((#,0000,7;;;7;;;;;;;;;; RX " _ !1"AQa2q#BR3CSb $%&'()*456789:DEFGHIJTUVWXYZcdefghijrstuvwxyz ^C !"#$%&'()*123456789:ABCDEFGHIJQRSTUVWXYZabcdefghijqrstuvwxyz ? jmssb1nK×.-F#:4r0$3]Qϟ5&Kˎٻ3hb,@& X Si2$q=݈h";E9O%AA[F*+6rd`pc_!#v#Bh䶃)@mE-Wpqbe']sXr_^תbRHɝO skzmHO#f kT\䑧2vEXt #&H]Q6홳1R MUV8U ѱdIah+bɉ]hXQfDUڟ 7$yl&Ϛ6bYʼnTaV\)'XLP,IJҵ]@a7.FV:fhmAB!@*Cnm5 uy#vFU0UaH\J!nSmh9vMP+pL O9vh"30e#^罭m싵_+/#r{Y D2d).+iZv~+) D@@C2ˠƏ2M NheKO1D9@Rm,!;5$tWEvv6w$e];@ pMG$E $H誮NI9>%hn0WP5mqrtiZ߮7(6i[sI4R鬃PmJ)1,$BJ]EԐAA+LLJY]ԭsiz\ ZfYڕ1*Xo]tU* @Mosϥԭn|^Թڕ7=ԭn|f8mJ1 QC%fRos*N& 8dy'l9Hey l&Y&n/A!xlETf*^tSgbbaܩd/3d#ʄuxԻg .|0#ld12^ol/zi!< /)@ap-mb|1DPS6xeĒN@,zlj ڃpnF!+sI:˴|YXdīMF [/oVIژId<\),CQA![Xͣ+o*N&LVufQc|:jnwe8jʐ"H#5f @cIpE X-sg"kk8{P.D1`̛:7^L`Ȭob X}d2!">M?%OlFxs\5cCD6'Kw=A^(I(/7 *kƂmHCXIQ"#0wl٭asbUψFx9- Gnʰ
ژId<\),CQA![Xͣ+o*N&LVufQc|:jnwe8jʐ"H#5f @cIpE X-sg"kk8{P.D1`̛:7^L`Ȭob X}d2!">M?%OlFxs\5cCD6'Kw=A^(I(/7 *kƂmHCXIQ"#0wl٭asbUψFx9- Gnʰ